Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lucas-Maximilian Matuszewski
Observed name:
L.-M. Matuszewski
Institutions:
University Hospital Carl Gustav Carus,
Technische Universität Dresden
Observed institutions:
University Hospital Carl Gustav Carus,
Technische Universität Dresden
ORCID:
0000-0002-3324-8999
Observed ORCID:
0000-0002-3324-8999
OpenAlex ID:
A5084722566
A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein–2 and zoledronic acid
2020
·
Deepak Bushan Raina
, Lucas-Maximilian Matuszewski
, et al.
·
Science Advances
·
78
PDF
Co-delivery of rhBMP-2 and zoledronic acid using calcium sulfate/hydroxyapatite carrier as a bioactive bone substitute to enhance and accelerate spinal fusion
2024
·
Xinggui Tian
, Corina Vater
, et al.
·
Bioactive Materials
·
14
Dose-Dependent Effects of a Novel Selective EP4 Prostaglandin Receptor Agonist on Treatment of Critical Size Femoral Bone Defects in a Rat Model
2021
·
Corina Vater
, Elisabeth Mehnert
, et al.
·
Biomedicines
·
7
PDF
Exploring an innovative augmentation strategy in spinal fusion: A novel selective prostaglandin EP4 receptor agonist as a potential osteopromotive factor to enhance lumbar posterolateral fusion
2025
·
Lisa Findeisen
, Xinggui Tian
, et al.
·
Biomaterials
·
4
Calcium Sulfate/hydroxyapatite-mediated Controlled Co-delivery of Bmp-2 and Zoledronic Acid Enhances Spinal Fusion
2024
·
X. Tian
, C. Vater
, et al.
·
Orthopaedic Proceedings
A Novel Selective Prostaglandin-receptor Ep4-agonist Promotes Spinal Fusion in Rats
2024
·
C. Vater
, X. Tian
, et al.
·
Orthopaedic Proceedings
Show more works
View as search
Works count:
6
Citation count:
103
H-index:
4
I10-index:
2
Year
Topic
Type